Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective
Authors
Keywords
-
Journal
Biomedicines
Volume 9, Issue 4, Pages 412
Publisher
MDPI AG
Online
2021-04-12
DOI
10.3390/biomedicines9040412
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mortality risk of COVID-19 in elderly males with comorbidities: a multi-country study
- (2021) Guangdi Li et al. Aging-US
- Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics
- (2021) Li Zeng et al. BIOCHEMICAL PHARMACOLOGY
- Genetic Variants of SARS-CoV-2—What Do They Mean?
- (2021) Adam S. Lauring et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vaccine makers in Asia rush to test jabs against fast-spreading COVID variant
- (2021) Gayathri Vaidyanathan NATURE
- Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK
- (2021) Louis du Plessis et al. SCIENCE
- Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De Clercq
- (2021) Guangdi Li et al. BIOCHEMICAL PHARMACOLOGY
- Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
- (2021) Emma C. Thomson et al. CELL
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
- (2021) Wilfredo F. Garcia-Beltran et al. CELL
- Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
- (2021) Jie Hu et al. Cellular & Molecular Immunology
- SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants
- (2021) John P. Moore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday
- (2021) Guangdi Li et al. MOLECULES
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- SARS-CoV-2 evolution during treatment of chronic infection
- (2021) Steven A. Kemp et al. NATURE
- Sixteen novel lineages of SARS-CoV-2 in South Africa
- (2021) Houriiyah Tegally et al. NATURE MEDICINE
- Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
- (2021) Nicholas G. Davies et al. NATURE
- Clinical significance of chemokine receptor antagonists
- (2020) Miao Miao et al. Expert Opinion on Drug Metabolism & Toxicology
- Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study
- (2020) Min Zhang et al. Hepatology International
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Authors’ response: SARS-CoV-2 detection by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- Population flow drives spatio-temporal distribution of COVID-19 in China
- (2020) Jayson S. Jia et al. NATURE
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins
- (2020) Tommy Tsan-Yuk Lam et al. NATURE
- The proximal origin of SARS-CoV-2
- (2020) Kristian G. Andersen et al. NATURE MEDICINE
- Phylogenetic network analysis of SARS-CoV-2 genomes
- (2020) Peter Forster et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis
- (2020) Elio Issa et al. mSystems
- Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment
- (2020) Takahiko Koyama et al. Pathogens
- Clinical characteristics of older and younger patients infected with SARS-CoV-2
- (2020) Zhiguo Zhou et al. Aging-US
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
- (2020) Qianqian Li et al. CELL
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity
- (2020) Inna G. Ovsyannikova et al. IMMUNOLOGICAL REVIEWS
- A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay
- (2020) Maria Artesi et al. JOURNAL OF CLINICAL MICROBIOLOGY
- A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
- (2020) Jingyun Yang et al. NATURE
- Evolution and epidemic spread of SARS-CoV-2 in Brazil
- (2020) Darlan S. Candido et al. SCIENCE
- Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California
- (2020) Xianding Deng et al. SCIENCE
- Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy
- (2020) Miao Miao et al. Drug Design Development and Therapy
- Geographic and Genomic Distribution of SARS-CoV-2 Mutations
- (2020) Daniele Mercatelli et al. Frontiers in Microbiology
- Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure
- (2020) Gyanendra Bahadur Chand et al. PeerJ
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
- (2020) Andrew Rambaut et al. Nature Microbiology
- Intra-genome variability in the dinucleotide composition of SARS-CoV-2
- (2020) Paul Digard et al. Virus Evolution
- Mapping genome variation of SARS-CoV-2 worldwide highlights the impact of COVID-19 super-spreaders
- (2020) Alberto Gómez-Carballa et al. GENOME RESEARCH
- Infectivity of SARS-CoV-2: there Is Something More than D614G?
- (2020) Saathvik R. Kannan et al. Journal of Neuroimmune Pharmacology
- The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2
- (2020) Natacha S. Ogando et al. JOURNAL OF VIROLOGY
- Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
- (2020) Barnaby E Young et al. LANCET
- Spike mutation D614G alters SARS-CoV-2 fitness
- (2020) Jessica A. Plante et al. NATURE
- A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
- (2020) Bethany Dearlove et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (2020) Wen Shi Lee et al. Nature Microbiology
- Temporal signal and the phylodynamic threshold of SARS-CoV-2
- (2020) Sebastian Duchene et al. Virus Evolution
- Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
- (2020) Erik Volz et al. CELL
- Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
- (2020) Fran Robson et al. MOLECULAR CELL
- Emergence of a Highly Fit SARS-CoV-2 Variant
- (2020) Ralph S. Baric NEW ENGLAND JOURNAL OF MEDICINE
- Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes
- (2020) Hong-Li Zeng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2
- (2020) Alexandra Popa et al. Science Translational Medicine
- The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
- (2020) Katarzyna Pancer et al. PLoS Pathogens
- SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay
- (2020) Victoria Elizondo et al. Emerging Microbes & Infections
- Evolution and genetic diversity of SARS-CoV-2 in Africa using whole genome sequences
- (2020) Babatunde Olarenwaju Motayo et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment
- (2019) Yali Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- Targeted selection of HIV-specific antibody mutations by engineering B cell maturation
- (2019) Kevin O. Saunders et al. SCIENCE
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
- (2013) K. Katoh et al. MOLECULAR BIOLOGY AND EVOLUTION
- KaKs_Calculator 2.0: A Toolkit Incorporating Gamma-Series Methods and Sliding Window Strategies
- (2010) Dapeng Wang et al. GENOMICS PROTEOMICS & BIOINFORMATICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started